Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Veng-Pedersen

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Clinical Pharmacokinetics|November 1, 1989
Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I)P Veng-Pedersen
Journal of Pharmaceutical Sciences|March 1, 1989
Mean time parameters dealing with the tissue distribution of drugs: limitations and extensionsP Veng-Pedersen
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1988
Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerationsP Veng-Pedersen
Journal of Pharmaceutical Sciences|August 1, 1984
Pulmonary absorption and excretion of compounds in the gas phase: theoretical pharmacokinetic and toxicokinetic analysisP Veng-Pedersen
Journal of Pharmaceutical Sciences|July 1, 1991
Stochastic interpretation of linear pharmacokinetics: a linear system analysis approachP Veng-Pedersen
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1996
Alternatives to structural modelingP Veng-Pedersen
Journal of Pharmaceutical Sciences|June 1, 1984
Model-independent steady-state plasma level predictions in autonomic nonlinear pharmacokinetics I: Derivation and theoretical analysisP Veng-Pedersen
Journal of Clinical Pharmacology|February 1, 1988
System approaches in pharmacokinetics: II. ApplicationsP Veng-Pedersen
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1988
Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? II. The response mapping operator (RMO) approachP Veng-Pedersen
Journal of Pharmaceutical Sciences|January 1, 1985
Novel method of calculating absolute bioavailability in nonlinear pharmacokineticsP Veng-Pedersen
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Clinical Pharmacokinetics|November 1, 1989
Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I)P Veng-Pedersen
Journal of Pharmaceutical Sciences|March 1, 1989
Mean time parameters dealing with the tissue distribution of drugs: limitations and extensionsP Veng-Pedersen
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1988
Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerationsP Veng-Pedersen
Journal of Pharmaceutical Sciences|August 1, 1984
Pulmonary absorption and excretion of compounds in the gas phase: theoretical pharmacokinetic and toxicokinetic analysisP Veng-Pedersen
Journal of Pharmaceutical Sciences|July 1, 1991
Stochastic interpretation of linear pharmacokinetics: a linear system analysis approachP Veng-Pedersen
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1996
Alternatives to structural modelingP Veng-Pedersen
Journal of Pharmaceutical Sciences|June 1, 1984
Model-independent steady-state plasma level predictions in autonomic nonlinear pharmacokinetics I: Derivation and theoretical analysisP Veng-Pedersen
Journal of Clinical Pharmacology|February 1, 1988
System approaches in pharmacokinetics: II. ApplicationsP Veng-Pedersen
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1988
Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? II. The response mapping operator (RMO) approachP Veng-Pedersen
Journal of Pharmaceutical Sciences|January 1, 1985
Novel method of calculating absolute bioavailability in nonlinear pharmacokineticsP Veng-Pedersen
Pageof 11